THX Pharma Société Anonyme (EPA:ALTHX)
France
· Delayed Price · Currency is EUR 1.840
+0.020 (1.10%)
Dec 5, 2025, 5:35 PM CET
EPA:ALTHX Revenue
THX Pharma Société Anonyme had revenue of 806.04K EUR in the half year ending June 30, 2025, with 229.90% growth. This brings the company's revenue in the last twelve months to 876.13K, down -61.32% year-over-year. In the year 2024, THX Pharma Société Anonyme had annual revenue of 2.28M with 670.55% growth.
Revenue (ttm)
876.13K
Revenue Growth
-61.32%
P/S Ratio
28.97
Revenue / Employee
87.61K
Employees
10
Market Cap
25.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.28M | 1.99M | 670.55% |
| Dec 31, 2023 | 296.33K | -118.57K | -28.58% |
| Dec 31, 2022 | 414.90K | 414.30K | 68,819.93% |
| Dec 31, 2021 | 602.00 | -294.01K | -99.80% |
| Dec 31, 2020 | 294.61K | -269.24K | -47.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |